BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Walters K, Bertoldo M, Handelsman D. Evidence from animal models on the pathogenesis of PCOS. Best Practice & Research Clinical Endocrinology & Metabolism 2018;32:271-81. [DOI: 10.1016/j.beem.2018.03.008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Bertoldo MJ, Caldwell ASL, Riepsamen AH, Lin D, Gonzalez MB, Robker RL, Ledger WL, Gilchrist RB, Handelsman DJ, Walters KA. A Hyperandrogenic Environment Causes Intrinsic Defects That Are Detrimental to Follicular Dynamics in a PCOS Mouse Model. Endocrinology 2019;160:699-715. [DOI: 10.1210/en.2018-00966] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
2 Hu M, Zhang Y, Guo X, Jia W, Liu G, Zhang J, Li J, Cui P, Sferruzzi-perri AN, Han Y, Wu X, Ma H, Brännström M, Shao LR, Billig H. Hyperandrogenism and insulin resistance induce gravid uterine defects in association with mitochondrial dysfunction and aberrant reactive oxygen species production. American Journal of Physiology-Endocrinology and Metabolism 2019;316:E794-809. [DOI: 10.1152/ajpendo.00359.2018] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 10.3] [Reference Citation Analysis]
3 Alam F, Abidi SH, Farooqi N, Jehan F, Rehman R. Oxidative stress and metformin: An in-vitro study on serum and primary human granulosa cell cultures. ELECTRON J GEN MED 2022;19:em381. [DOI: 10.29333/ejgm/12037] [Reference Citation Analysis]
4 Ruddenklau A, Campbell RE. Neuroendocrine Impairments of Polycystic Ovary Syndrome. Endocrinology 2019;160:2230-42. [PMID: 31265059 DOI: 10.1210/en.2019-00428] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
5 Laganà AS, Garzon S, Casarin J, Franchi M, Ghezzi F. Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach. Trends Endocrinol Metab 2018;29:768-80. [PMID: 30270194 DOI: 10.1016/j.tem.2018.09.001] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 16.5] [Reference Citation Analysis]
6 Francisco FA, Saavedra LPJ, Junior MDF, Barra C, Matafome P, Mathias PCF, Gomes RM. Early AGEing and metabolic diseases: is perinatal exposure to glycotoxins programming for adult-life metabolic syndrome? Nutr Rev 2021;79:13-24. [PMID: 32951053 DOI: 10.1093/nutrit/nuaa074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Mossa F, Ireland JJ. Physiology and endocrinology symposium: Anti-Müllerian hormone: a biomarker for the ovarian reserve, ovarian function, and fertility in dairy cows. J Anim Sci 2019;97:1446-55. [PMID: 30668706 DOI: 10.1093/jas/skz022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
8 Zhang X, Zheng Y, Guo Y, Lai Z. The Effect of Low Carbohydrate Diet on Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials. Int J Endocrinol 2019;2019:4386401. [PMID: 31885557 DOI: 10.1155/2019/4386401] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 8.7] [Reference Citation Analysis]
9 Stepto NK, Moreno-Asso A, McIlvenna LC, Walters KA, Rodgers RJ. Molecular Mechanisms of Insulin Resistance in Polycystic Ovary Syndrome: Unraveling the Conundrum in Skeletal Muscle? J Clin Endocrinol Metab 2019;104:5372-81. [PMID: 30938770 DOI: 10.1210/jc.2019-00167] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
10 Arroyo P, Ho BS, Sau L, Kelley ST, Thackray VG. Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome. PLoS One 2019;14:e0223274. [PMID: 31568518 DOI: 10.1371/journal.pone.0223274] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
11 Tonellotto Dos Santos J, Escarião da Nóbrega J Jr, Serrano Mujica LK, Dos Santos Amaral C, Machado FA, Manta MW, Rizzetti TM, Zanella R, Fighera R, Antoniazzi AQ, Gonçalves PBD, Comim FV. Prenatal Androgenization of Ewes as a Model of Hirsutism in Polycystic Ovary Syndrome. Endocrinology 2018;159:4056-64. [PMID: 30376052 DOI: 10.1210/en.2018-00781] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Morsi AA, A Mersal E, Razik H Farrag A, M Abdelmoneim A, M Abdelmenem A, S Salim M. Histomorphological Changes in a Rat Model of Polycystic Ovary Syndrome and the Contribution of Stevia Leaf Extract in Modulating the Ovarian Fibrosis, VEGF, and TGF-β Immunoexpressions: Comparison with Metformin. Acta Histochem Cytochem 2022;55:9-23. [PMID: 35444350 DOI: 10.1267/ahc.21-00081] [Reference Citation Analysis]
13 Rodriguez Paris V, Edwards MC, Aflatounian A, Bertoldo MJ, Ledger WL, Handelsman DJ, Gilchrist RB, Walters KA. Pathogenesis of Reproductive and Metabolic PCOS Traits in a Mouse Model. J Endocr Soc 2021;5:bvab060. [PMID: 34056500 DOI: 10.1210/jendso/bvab060] [Reference Citation Analysis]
14 Sudhakaran G, Guru A, Hari Deva Muthu B, Murugan R, Arshad A, Arockiaraj J. Evidence-based hormonal, mutational, and endocrine-disrupting chemical-induced zebrafish as an alternative model to study PCOS condition similar to mammalian PCOS model. Life Sci 2022;291:120276. [PMID: 34990650 DOI: 10.1016/j.lfs.2021.120276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Peecher DL, Binder AK, Gabriel KI. Rodent models of mental illness in polycystic ovary syndrome: the potential role of hypothalamic-pituitary-adrenal dysregulation and lessons for behavioral researchers. Biol Reprod 2019;100:590-600. [PMID: 30388193 DOI: 10.1093/biolre/ioy233] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Roy S, Huang B, Sinha N, Wang J, Sen A. Androgens regulate ovarian gene expression by balancing Ezh2-Jmjd3 mediated H3K27me3 dynamics. PLoS Genet 2021;17:e1009483. [PMID: 33784295 DOI: 10.1371/journal.pgen.1009483] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Tu M, Wu Y, Mu L, Zhang D. Long non-coding RNAs: novel players in the pathogenesis of polycystic ovary syndrome. Ann Transl Med 2021;9:173. [PMID: 33569475 DOI: 10.21037/atm-20-5044] [Reference Citation Analysis]
18 Ryu Y, Kim SW, Kim YY, Ku SY. Animal Models for Human Polycystic Ovary Syndrome (PCOS) Focused on the Use of Indirect Hormonal Perturbations: A Review of the Literature. Int J Mol Sci 2019;20:E2720. [PMID: 31163591 DOI: 10.3390/ijms20112720] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
19 Sinha N, Roy S, Huang B, Wang J, Padmanabhan V, Sen A. Developmental programming: prenatal testosterone-induced epigenetic modulation and its effect on gene expression in sheep ovary†. Biol Reprod 2020;102:1045-54. [PMID: 31930385 DOI: 10.1093/biolre/ioaa007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
20 Sucquart IE, Nagarkar R, Edwards MC, Rodriguez Paris V, Aflatounian A, Bertoldo MJ, Campbell RE, Gilchrist RB, Begg DP, Handelsman DJ, Padmanabhan V, Anderson RA, Walters KA. Neurokinin 3 Receptor Antagonism Ameliorates Key Metabolic Features in a Hyperandrogenic PCOS Mouse Model. Endocrinology 2021;162:bqab020. [PMID: 33522579 DOI: 10.1210/endocr/bqab020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Zhang S, Tu H, Zhu J, Liang A, Huo P, Shan K, He J, Zhao M, Chen X, Lei X. Dendrobium nobile Lindl. polysaccharides improve follicular development in PCOS rats. Int J Biol Macromol 2020;149:826-34. [PMID: 31978473 DOI: 10.1016/j.ijbiomac.2020.01.196] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
22 Chen Y, Miao J, Lou G. Knockdown of circ-FURIN suppresses the proliferation and induces apoptosis of granular cells in polycystic ovary syndrome via miR-195-5p/BCL2 axis. J Ovarian Res 2021;14:156. [PMID: 34784951 DOI: 10.1186/s13048-021-00891-0] [Reference Citation Analysis]
23 Younas A, Hussain L, Shabbir A, Asif M, Hussain M, Manzoor F. Effects of Fagonia indica on Letrozole-Induced Polycystic Ovarian Syndrome (PCOS) in Young Adult Female Rats. Evid Based Complement Alternat Med 2022;2022:1397060. [PMID: 35664938 DOI: 10.1155/2022/1397060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Rodriguez Paris V, Bertoldo MJ. The Mechanism of Androgen Actions in PCOS Etiology. Med Sci (Basel) 2019;7:E89. [PMID: 31466345 DOI: 10.3390/medsci7090089] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
25 Li N, Yang C, Xie H, Liu Y, Liao Y. Effects of Aerobic Exercise on Rats with Hyperandrogenic Polycystic Ovarian Syndrome. Int J Endocrinol 2021;2021:5561980. [PMID: 34422044 DOI: 10.1155/2021/5561980] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
26 Aguilera N, Salas-pérez F, Ortíz M, Álvarez D, Echiburú B, Maliqueo M. Rodent models in placental research. Implications for fetal origins of adult disease. Anim Reprod 2022;19:e20210134. [DOI: 10.1590/1984-3143-ar2021-0134] [Reference Citation Analysis]
27 Shahid R, Iahtisham-Ul-Haq, Mahnoor, Awan KA, Iqbal MJ, Munir H, Saeed I. Diet and lifestyle modifications for effective management of polycystic ovarian syndrome (PCOS). J Food Biochem 2022;:e14117. [PMID: 35199348 DOI: 10.1111/jfbc.14117] [Reference Citation Analysis]
28 Rodriguez Paris V, Solon-Biet SM, Senior AM, Edwards MC, Desai R, Tedla N, Cox MJ, Ledger WL, Gilchrist RB, Simpson SJ, Handelsman DJ, Walters KA. Defining the impact of dietary macronutrient balance on PCOS traits. Nat Commun 2020;11:5262. [PMID: 33067453 DOI: 10.1038/s41467-020-19003-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
29 Ashkar F, Eftekhari MH, Tanideh N, Koohpeyma F, Mokhtari M, Irajie C, Iraji A. Effect of hydroalcoholic extract of Berberis integerrima and resveratrol on ovarian morphology and biochemical parameters in Letrozole-induced polycystic ovary syndrome rat model: An experimental study. Int J Reprod Biomed 2020;18:637-50. [PMID: 32923930 DOI: 10.18502/ijrm.v13i8.7505] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
30 Zhang Y, Zhao W, Xu H, Hu M, Guo X, Jia W, Liu G, Li J, Cui P, Lager S, Sferruzzi-Perri AN, Li W, Wu XK, Han Y, Brännström M, Shao LR, Billig H. Hyperandrogenism and insulin resistance-induced fetal loss: evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome. J Physiol 2019;597:3927-50. [PMID: 31206177 DOI: 10.1113/JP277879] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
31 Xiong T, Rodriguez Paris V, Edwards MC, Hu Y, Cochran BJ, Rye KA, Ledger WL, Padmanabhan V, Handelsman DJ, Gilchrist RB, Walters KA. Androgen signaling in adipose tissue, but less likely skeletal muscle, mediates development of metabolic traits in a PCOS mouse model. Am J Physiol Endocrinol Metab 2022. [PMID: 35658542 DOI: 10.1152/ajpendo.00418.2021] [Reference Citation Analysis]
32 Cox MJ, Edwards MC, Rodriguez Paris V, Aflatounian A, Ledger WL, Gilchrist RB, Padmanabhan V, Handelsman DJ, Walters KA. Androgen Action in Adipose Tissue and the Brain are Key Mediators in the Development of PCOS Traits in a Mouse Model. Endocrinology 2020;161:bqaa061. [PMID: 32301482 DOI: 10.1210/endocr/bqaa061] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
33 Akbarinejad V, Gharagozlou F, Vojgani M, Shourabi E, Makiabadi MJM. Inferior fertility and higher concentrations of anti-Müllerian hormone in dairy cows with longer anogenital distance. Domest Anim Endocrinol 2019;68:47-53. [PMID: 30851696 DOI: 10.1016/j.domaniend.2019.01.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
34 Hartanti MD, Rosario R, Hummitzsch K, Bastian NA, Hatzirodos N, Bonner WM, Bayne RA, Irving-Rodgers HF, Anderson RA, Rodgers RJ. Could perturbed fetal development of the ovary contribute to the development of polycystic ovary syndrome in later life? PLoS One 2020;15:e0229351. [PMID: 32078641 DOI: 10.1371/journal.pone.0229351] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
35 Moore AM, Lohr DB, Coolen LM, Lehman MN. Prenatal Androgen Exposure Alters KNDy Neurons and Their Afferent Network in a Model of Polycystic Ovarian Syndrome. Endocrinology 2021;162:bqab158. [PMID: 34346492 DOI: 10.1210/endocr/bqab158] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Walters KA, Gilchrist RB, Ledger WL, Teede HJ, Handelsman DJ, Campbell RE. New Perspectives on the Pathogenesis of PCOS: Neuroendocrine Origins. Trends Endocrinol Metab 2018;29:841-52. [PMID: 30195991 DOI: 10.1016/j.tem.2018.08.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
37 Ho VNA, Pham TD, Nguyen NT, Hoang HLT, Ho TM, Vuong LN. The impact of hyperandrogenism on the outcomes of ovulation induction using gonadotropin and intrauterine insemination in women with polycystic ovary syndrome. Clin Exp Reprod Med 2022;49:127-34. [DOI: 10.5653/cerm.2022.05204] [Reference Citation Analysis]
38 Ferreira SR, Vélez LM, F Heber M, Abruzzese GA, Motta AB. Prenatal androgen excess alters the uterine peroxisome proliferator-activated receptor (PPAR) system. Reprod Fertil Dev 2019. [PMID: 31039921 DOI: 10.1071/RD18432] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]